AxoGen Inc
NASDAQ:AXGN

Watchlist Manager
AxoGen Inc Logo
AxoGen Inc
NASDAQ:AXGN
Watchlist
Price: 15.71 USD -2.66% Market Closed
Market Cap: 722.8m USD

Wall Street
Price Targets

AXGN Price Targets Summary
AxoGen Inc

Wall Street analysts forecast AXGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AXGN is 25.37 USD with a low forecast of 20.2 USD and a high forecast of 31.5 USD.

Lowest
Price Target
20.2 USD
29% Upside
Average
Price Target
25.37 USD
62% Upside
Highest
Price Target
31.5 USD
101% Upside
AxoGen Inc Competitors:
Price Targets
HYPR
Hyperfine Inc
19% Upside
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
32% Upside
SOON
Sonova Holding AG
18% Upside
IRTC
iRhythm Technologies Inc
4% Upside
041830
InBody Co Ltd
39% Upside
099190
I Sens Inc
49% Upside
2291
Lepu Scientech Medical Technology Shanghai Co Ltd
35% Upside
688617
APT Medical Inc
15% Upside

Revenue
Forecast

Revenue Estimate
AxoGen Inc

For the last 13 years the compound annual growth rate for AxoGen Inc's revenue is 33%. The projected CAGR for the next 3 years is 16%.

33%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
AxoGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

Net Income Estimate
AxoGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AXGN's stock price target?
Price Target
25.37 USD

According to Wall Street analysts, the average 1-year price target for AXGN is 25.37 USD with a low forecast of 20.2 USD and a high forecast of 31.5 USD.

What is AxoGen Inc's Revenue forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for AxoGen Inc's revenue is 33%. The projected CAGR for the next 3 years is 16%.

Back to Top